Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HPGDS inhibitor 1 是口服具有活性的HPGDS 选择性抑制剂,在酶和细胞分析中的IC50值分别为 0.6 nM 和 32 nM,但对 L-PGDS、mPGES、COX-1、COX-2 、5-LOX 无抑制作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 478 | 现货 | ||
2 mg | ¥ 749 | 现货 | ||
5 mg | ¥ 1,530 | 现货 | ||
10 mg | ¥ 2,680 | 现货 | ||
25 mg | ¥ 4,530 | 现货 | ||
50 mg | ¥ 6,470 | 现货 | ||
100 mg | ¥ 8,830 | 现货 | ||
500 mg | ¥ 17,700 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,680 | 现货 |
产品描述 | HPGDS inhibitor 1 is a novel and selective inhibitor for Hematopoietic Prostaglandin D Synthase (HPGDS) with an IC50 Value of 0.7 nM. |
靶点活性 | HPGDS:0.7 nM. |
激酶实验 | Kinetic characterization of Abl inhibition: The ATP/NADH-coupled assay system in a 96-well format is used to determine the initial velocity of Abl tyrosine kinase catalyzed peptide phosphorylation. The reaction mixture contained 20 mM Tris-HCl, (pH 8.0), 50 mM NaCl, 10 mM MgCl2, 2 mM PEP [2-(Phosphonooxy)- 2-propenoic acid) and 20 μg Abl peptide substrate (EAIYAAPFAKKK), fixed or varied (to determine inhibitor kinetic parameters) concentration of inhibitor applied, 1/50 of the final reaction mixture volume of PK/LDH enzyme (pyruvate kinase/lactic dehydrogenase enzymes from rabbit muscle), 160 μM NADH, 0.16 μM Abl, and ATP added last to start the reaction. Absorbance data are collected every 20s at 340 nm using a SpectraMax M5 Microplate Reader. |
别名 | HPGDS-inhibitor-1 |
分子量 | 381.37 |
分子式 | C19H19F4N3O |
CAS No. | 1033836-12-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (144.22 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6221 mL | 13.1106 mL | 26.2213 mL | 65.5531 mL |
5 mM | 0.5244 mL | 2.6221 mL | 5.2443 mL | 13.1106 mL | |
10 mM | 0.2622 mL | 1.3111 mL | 2.6221 mL | 6.5553 mL | |
20 mM | 0.1311 mL | 0.6555 mL | 1.3111 mL | 3.2777 mL | |
50 mM | 0.0524 mL | 0.2622 mL | 0.5244 mL | 1.3111 mL | |
100 mM | 0.0262 mL | 0.1311 mL | 0.2622 mL | 0.6555 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
HPGDS inhibitor 1 1033836-12-2 Immunology/Inflammation PGE Synthase Inhibitor Prostaglandin E synthase inhibit PGD2 orally HPGDS inhibitor-1 HPGDS HPGDS-inhibitor-1 PGE synthase asthma HPGDS inhibitor1 inhibitor